HomeStocksADVENZYMES

A

Advanced Enzyme Tech

ADVENZYMES Share PriceHealthcare

₹ 297.70

4.50 (1.53%)profit
as on 07 Sep 2026 at 02:17 PM
views6.8K
portfolio560
analyst100% Buy
Overview
Pros & Cons
News
History
Fundamentals
Investment Returns
Technicals
Financials
Balance Sheet
Cash Flow
Corporate Actions
Peers

Advanced Enzyme Tech Share Price Today

Today Advanced Enzyme Tech opened at 293.20 while its previous close was at 293.20. In todays trading session ADVENZYMES reached a high of 297.90 and low of 292.20. The average traded price for today is 295.98. The 50 DMA stands at 311.62 and 200 DMA is at 315.04. Looking at intraday trend, the stock is in Uptrend.

50 DMA: 311.62200 DMA: 315.04
chartsarrowTradingViewarrow

Get 10+ Layouts, 100+ Indicators, Custom Timeframes & All Drawing Tools for FREE.

Use Chart

ADVENZYMES Stock Performance

Markets Today

High

297.90

Low

292.20

Open at

293.20

Prev Close

293.20

Volumes

1,28,373

Avg Price

295.98

Lower Circuit

234.60

Upper Circuit

351.80

Last Traded Details

Quantity

4

Time

14:17:27

Price Movement

292.20297.90
1.88%Loss
down side
up side
0.07%Profit

Historical Performance

3 M High

386.35

3 M Low

291.05

1 Yr High

419.00

1 Yr Low

251.95

3 Yr High

571.00

3 Yr Low

251.95

5 Yr High

571.00

5 Yr Low

225.00

1-Year Performance

251.95419.00
18.16%Loss
down side
up side
28.95%Profit
View In-Deptharrow

ADVENZYMES Pros and Cons

byfuzz AI

Finance costs eased from ₹8 Cr in Q1 FY26 to ₹6 Cr in Q1 FY27, lowering the interest burden.

Europe revenue recovered from ₹95 Cr in Q4 FY26 to ₹132 Cr in Q1 FY27, highlighting regional demand strength.

Asia revenue grew from ₹177 Cr in Q1 FY26 to ₹242 Cr in Q1 FY27, sustaining overseas expansion.

Polunin Capital increased its stake from 1.44% in Q2 FY26 to 2.58% in Q1 FY27, showing renewed accumulation.

Orbimed Asia III maintained a constant 12.07% stake from Q1 FY26 to Q1 FY27, anchoring the institutional base.

EBITDA margin contracted from 33% in Q2 FY26 to 27% in Q1 FY27, reflecting pricing and cost pressures.

Net profit declined from ₹453 Cr in Q4 FY26 to ₹386 Cr in Q1 FY27, signaling earnings headwinds.

Operating expenses stayed elevated at ₹1,487 Cr in Q1 FY27 compared to ₹1,328 Cr in Q3 FY26, squeezing profitability.

India revenue softened from ₹1,061 Cr in Q4 FY26 to ₹937 Cr in Q1 FY27, indicating domestic demand weakness.

ICICI Prudential MF reduced its stake from 3.08% in Q1 FY26 to 0.72% in Q1 FY27, showing fund exit.

fuzz Insights
Positive

European sales bounced back to soften the overall dip.

Positive

Big investor buying helped lift the share price.

Neutral

Factory earnings dropped, but final profit stayed steady.

Neutral

More industrial sales did not mean more cash.

Neutral

New manufacturing sales grew, but profit share shrank.

Negative

Rising costs are eating into every rupee of sales.

ADVENZYMES Analyst Rating

Buy

Analysts have suggested that investors can Buy this Stock

- By Refinitiv from 1 analysts

Buy

100%

Hold

0%

Sell

0%

Get forecast for Price, ROA & ROE based on analyst ratings.

Get Forecast

ADVENZYMES Latest News

View Allarrow

ADVENZYMES Share Price History

View In-Deptharrow

ADVENZYMES Fundamentals

Company Valuation

Market Cap (₹ Cr.)

3,334

PE Ratio

19.10

PB Ratio

2.01

Dividend Yield

1.82%

ROE

10.31%

ROCE

13.58%

Book Value (₹)

145.72

Face Value (₹)

2.00

Analyse ADVENZYMES with 12+ custom fundamentals and financial ratios.

Analyse Now

Share Holding Pattern

Held ByJun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoters
43.08%43.07%43.04%43.26%43.24%
Domestic Institutional Investors (DII)
8.45%6.41%5.51%5.41%4.78%
Foreign Institutional Investors (FII)
23.46%25.41%25.86%25.49%26.71%
Public Investors
16.92%16.95%17.44%17.57%16.94%
Government
0.00%0.00%0.00%0.00%0.00%

Promoters

Domestic Institutional Investors (DII)

Foreign Institutional Investors (FII)

Public Investors

Government

View In-Deptharrow

Advanced Enzyme Tech Return Calculator

You have invested
Investment Period

Current value of ₹1,00,000 invested 5 years ago, as on today

₹ 0

Loss

₹ 1,00,000 (22.58%)

Invest Now

Note: Past profits do not guarantee future returns.

ADVENZYMES Investment Returns

1 Week

1 Month

3 Months

6 Months

9 Months

View In-Deptharrow

Create Wealth in Longterm with Weekly and Monthly SIP in Stocks.

Start SIP

ADVENZYMES Technicals

Moving Averages

PeriodSimpleSignal
5-SMA294.31Bearish
10-SMA296.83Bearish
20-SMA299.24Bearish
50-SMA311.62Bearish
100-SMA334.43Bearish
200-SMA315.04Bearish

Technical Indicators

IndicatorValueAction
RSI(14)37.98Neutral
ATR(14)8.89Less Volatile
STOCH(9,6)18.69Oversold
STOCH RSI(14)30.52Neutral
MACD(12,26)0.18Bullish
ADX(14)13.05Weak Trend

Summary of Technical Indicators for ADVENZYMES

View In-Deptharrow

Margin on ADVENZYMES

Order TypeMargin to PayLeverageQuantityTrade ValueMargin AmountActions

*Calculated on NSE. Applicable on all exchanges. Margins are subject to change from time to time or may be withdrawn under volatile market conditions. Intraday Orders are square-off automatically at 03:19 pm on NSE / BSE or on hitting 80% of margin utilisation (whichever earlier).

ADVENZYMES Financials Summary

View By:
Revenue
EBITDA
Net Profit
EPS
Revenue

In Crores

Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
195195192211203

ADVENZYMES Financials

View by

Income Statement

In Cr

Quarterly StatementJun 2025Sep 2025Dec 2025Mar 2026Jun 2026
195195192211203
Expenses130125123140139
6570697164
Operating Profit5660496351
Operating Profit Margin %30%33%29%31%27%
Other Income91020713
Interest11111
Depreciation1010101010
5560586054
Tax %26%25%26%24%28%
Net Profit4045434539
EPS44443

Balance Sheet

In Cr

Yearly Balance SheetMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
1,2681,4221,5361,6211,839
Fixed Assets619649650679692
Current Assets6047228108801,044
Capital Work in Progress1522412251
Investments102360403480584
Other Assets531392442441512
1,2681,4221,5361,6211,839
Current Liabilities607810697107
Non Current Liabilities6760585649
1,1401,2841,3711,4691,683
Reserve & Surplus1,0661,2131,3021,3991,609
Share Capital2222222222
Minority Interest5249474851

Cash Flow

In Cr

Yearly Cash FlowMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Activities122140141143157
Investing Activities2-286-65-90-72
Financing Activities-49-26-59-73-70
Net Cash Flow75-17117-2015
View In-Deptharrow

Corporate Actions

DateCorporate ActionInformation
8th Aug 2026, Saturday
QUARTERLY RESULT ANNOUNCEMENTStock Result
Q1 FY 26-27 Results
info
24th Jul 2026, Friday
DIVIDENDDividend
Final Dividend of ₹1.35/share
9th May 2026, Saturday
QUARTERLY RESULT ANNOUNCEMENTStock Result
Q4 FY 26-27 Results
info
31st Jan 2026, Saturday
QUARTERLY RESULT ANNOUNCEMENTStock Result
Q3 FY 25-26 Results
info
12th Nov 2025, Wednesday
QUARTERLY RESULT ANNOUNCEMENTStock Result
Q2 FY 25-26 Results
info

The above dates are ex-dates.

View Allarrow

Check ADVENZYMES latest Company Filings, Investor Presentation & Conference Call details.

Read Now

ADVENZYMES Revenue Growth

All values are in Crores

Revenue

Profit

Loss

Financial YearRevenueRevenue GrowthNet ProfitProfit Growth
FY 2025-26516
25.01% profit
132
28.69% profit
FY 2024-25413
-2.68% Loss
102
-5.27% Loss
FY 2023-24424
32.04% profit
108
94.72% profit

Top Mutual Funds Invested in ADVENZYMES

ADVENZYMES Popular Brands

ADVENZYMES Similar Stocks

Stock NamePrice
Anthem Biosciences

A

Anthem Biosciences

939.85+0.62%profit
Vivo Bio Tech

V

Vivo Bio Tech

18.98+0.96%profit
View Allarrow

NSE Indices Today

Index NamePrice
View Allarrow

Top Gainers Today

Stock NamePrice
View Allarrow

Top Losers Today

Stock NamePrice
View Allarrow

Open IPOs

View All IPOsarrow

Calculators

Brokerage Calculator

Brokerage Calculator

Margin Calculator

Margin Calculator

MTF Calculator

MTF Calculator

Stock Return Calculator

Stock Return Calculator

Stock Average Calculator

Stock Average Calculator

View Allarrow

What's New In The Market

View Allarrow

FAQs on ADVENZYMES

Advanced Enzyme Tech share price as of today is ₹ 297.70 as on 07 Sep 2026 at 02:17 PM.
The 52W high of Advanced Enzyme Tech is ₹ 419.00 and 52W low is ₹ 251.95 as of 07 Sep 2026 at 14:17.
The past returns of Advanced Enzyme Tech share are -
  • Past 1 year: -12.97%
  • Past 3 years: -8.16%
  • Past 5 years: -22.58%
The PE and PB ratio of Advanced Enzyme Tech stands at 19.10 and 2.01 respectively as on 07 Sep 2026 at 14:17.
The EPS of Advanced Enzyme Tech is 3.31 for the quarter ended Jun 2026 and 15.08 for the financial year 2025-26.
The shareholding pattern of Advanced Enzyme Tech is as follows:
  • DIIs - 4.78%
  • FII - 26.71%
  • Promoters - 43.24%
  • Public Investors 16.94%
  • Goverenment - 0.00%
Yes, you can buy shares of Advanced Enzyme Tech online by opening Demat account with Dhan.
If you are a Dhan user already, you can buy Advanced Enzyme Tech stocks from Dhan Trading App or Web Trading Platform. If you are new to Dhan follow the below steps:
  1. Download the Dhan App to Open a Demat Account
  2. Navigate to the “Money Tab”
  3. Add money to your account
  4. Search for Advanced Enzyme Tech share
  5. Tap on “Buy”
With Dhan you can start a daily, weekly or monthly SIP in Advanced Enzyme Tech.
You can easily buy the shares of Advanced Enzyme Tech even after the markets are closed using the After Market Order feature on Dhan Trading App.


Invest & Trade with a Trading
Platform That's icon

Open your Dhan Account in minutes!


border
logo

Join our Community

community logo

Follow us on

twitter
telegram
Linkedin
youtube
instagram
facebook

built with love
for Indians who love to invest & trade

raise

We are part of Raise Financial Services

raise
raise

Explore  |  Sitemap


*All securities mentioned on this website are exemplary and not recommendatory.

*Current prices on the website are delayed by 15 mins, login to check live prices.

We are bullish on India, we are bullish on India's prospects to be one of the largest economies in the world. We believe that the stock market provides a unique opportunity for all of India's traders and investors to participate in the growth story of the country.

Yet, most investing & trading platforms in India have remained more or less the same over the past decade. Times have changed and retail traders and investors have become smarter about managing their trades and money. Modern traders & investors require an online trading platform that helps them keep up with the technological advancements of our time.

That's why we're building Dhan - to help you trade, to help you invest, and to help you participate in India's growth stock via the stock market with awesome features and an incredible experience.

We are doing so by giving you access to not just one but 6 products within the Dhan ecosystem:


This means that with Dhan, you'll be able to start:


Lakhs of users already trust Dhan for their online stock trading and investing needs. Dhan is growing rapidly because of the love we receive from SuperTraders and Long-Term Investors who acknowledge that the platform is innovating for them, building super useful features that help them do everything from investing in stock market to trading F&O like a pro on the Tradingview charts and much more.

While we are growing, we will always remember why we started building in the first place - you. Our user-first approach will always be at the heart of our philosophy. Come join us on this incredible journey!

Try it out, you can close your account at anytime using this link.

©2021-2026 Raise Securities Private Limited (formerly Moneylicious Securities Private Limited). All rights reserved. CIN: U74999MH2012PTC433549 Raise Securities is part of Raise Financial Services and works closely with Raise Partners across services.

SEBI Stock Broker Registration No: INZ000006031 | Depository Participant (CDSL) ID: IN-DP-289-2016 | SEBI Research Analyst Registration No: INH000023357
Exchange Membership No. : NSE: 90133 | BSE: 6593 | MCX: 56320
Registered & Corporate Office: Unit No. 2201, 22nd Floor, Gold Medal Avenue, S.V. Road, Beside Patel Petrol Pump, Piramal Nagar, Goregaon West, Mumbai – 400104, Customer Care: 9987761000.

Details of client bank account

For any query / feedback / clarifications, email at help@dhan.co.

In case of grievances for any of the services rendered by Raise Securities Private Limited, please write to grievance@dhan.co (for NSE, BSE and MCX) or grievancedp@dhan.co (for Depository Participant). Please ensure that you carefully read the Risk Disclosure Document as prescribed by SEBI, our Terms of Use and Privacy Policy. Compliance Officer: Mr. Manish Garg and Mobile: 8655740961 Email: complianceofficer@dhan.co To lodge your complaints using SEBI SCORES, click here.


Disclaimer: All communications with the client via chat, phone, or email are for support purposes only. Any commitments or statements made by the agent (human or virtual) shall not be binding on the company.


DHAN is a brand owned by Raise Securities Private Limited. All DHAN clients are registered under Raise Securities Private Limited. Clients are advised to refer to our company as Raise Securities Private Limited when communicating with regulatory authorities.


Procedure to file a complaint on SEBI SCORES/SMART ODR Portal: Register on SCORES portal. Mandatory details for filing complaints on SCORES: Name, PAN, Address, Mobile Number, E-mail ID. Benefits: Effective Communication, Speedy redressal of the grievances. You may refer the website https://scores.sebi.gov.in/ for more information. You may also download the SEBI Scores app to log a complaint Android: https://play.google.com store apps sebiscores iOS: https://apps.apple.com app sebiscores.


Disclaimer: Investment in the securities market are subject to market risks, read all the related documents carefully before investing. Brokerage will not exceed the SEBI prescribed limit


Attention investors:

  1. Stock brokers can accept securities as margins from clients only by way of pledge in the depository system w.e.f September 01, 2020.
  2. Update your e-mail and phone number with your stock broker / depository participant and receive OTP directly from depository on your e-mail and/or mobile number to create pledge.
  3. Check your securities / MF / bonds in the consolidated account statement issued by NSDL/CDSL every month.

Note: As a policy we do not give stock tips or recommendations and have not authorized anyone to give this on behalf of us. If you know anyone claiming to be a part of Dhan / / Raise or our associate companies or partners and offering such services, please report us on help@dhan.co. Important Information for Investors: To prevent unauthorized transactions in your trading / demat account, do not share your account details, credentials or any personal details with anyone. Keep your mobile number updated with your Stock Broker, Depository Participant and ensure that the same is registered with Stock Exchanges, Depository and KRAs. You will receive alerts and information on your registered mobile number / email for debit and other important transactions in your demat account directly from CDSL / Exchange on the same day. KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (Stock Broker, DP, Mutual Fund, etc.), you need not undergo the same process again when you approach another intermediary. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account. This is issued in the interest of investors.


Investors should be cautious on unsolicited emails and SMS advising to buy, sell or hold securities and trade only on the basis of informed decision. Investors are advised to invest after conducting appropriate analysis of respective companies and not to blindly follow unfounded rumours, tips etc. Further, you are also requested to share your knowledge or evidence of systemic wrongdoing, potential frauds or unethical behaviour through the anonymous portal facility provided on BSE & NSE website. Issued in the interest of the investors.


Raise Securities Private Limited also known as Dhan is only an order collection platform that collects orders on behalf of clients and places them on BSE StarMF for execution. Client expressly agrees that Dhan is not liable or responsible and does not represent or warrant any damages regarding non- execution of orders or any incorrect execution of orders with regard to the funds chosen by the client or due to, but not being limited to, any link/system failure, delay in transfer of the funds on account of any unforeseen circumstances/issues in the banking system/payment aggregators or any other problems that may result in a delay in crediting the funds into the BSE Star MF's bank account. Raise Securities Private Limited (Dhan) does not engage in proprietary trading on its own account.


Mutual fund investments are subject to market risks, read all scheme related documents carefully before investing. Dhan is not a distributor or agent of any mutual fund. Mutual Funds are not exchange-traded products. Any related disputes will not have access to the Exchange-investor redressal forum or arbitration mechanism. For other disclaimers please refer https://dhan.co/advertisement-disclaimer/


Download client registration documents (Rights & Obligations, Risk Disclosure Document, Do's & Don'ts) in vernacular language: BSE | NSE | MCX


Kindly, read the Advisory Guidelines of BSE | NSE | MCX for investors as prescribed by the exchange with reference to their circular dated 27th August, 2021 regarding investor awareness and safeguarding client's assets


Important Links: SEBI | BSE | NSE | MCX | CDSL | SCORES | ODR Portal | Investor Charter for Stock Brokers | Investor Charter for DP | Investor Charter for Research Analyst | UCC Advisory | e-Voting for Shareholders | NCL Client Collateral details | MCXCCL Client Collateral details

Important Information: Terms of Usage | Disclaimers | Privacy Policy | Grievances | Grievances RA | Risk Management Policy | Risk Disclosure | Advertisement Disclaimer | Referral Terms & Conditions | Saarthi 2.0 Mobile App for Investors | Master Circular for Online Dispute Resolution